TechnoPhage, SA

Launched in 2005, TechnoPhage is an innovative biopharmaceutical company committed to the R&D of new biological molecules in several therapeutic areas, such as infection, neuroscience, and ophthalmology. TechnoPhages strategy is based on developing new therapeutics from early discovery to clinical development, including in-house capacity for process development, and GMP production. The company has recently launched its own GMP manufacturing plant specialized in the production of biologics such as bacteriophages and antibody fragments. TechnoPhage is focused on increasing its pipeline of proprietary technologies and deriving products. This is achieved through an active R&D program and collaboration agreements with national and international...

Small domain antibodies,bacteriophage therapeutics,screening platforms in zebrafish,biotechnology,preclinical development,clinical trials,infection,neuroscience,and ophthalmology

Technophage, sa operates in the Biotechnology research industry.

Technophage, sa's revenue is 11m - 100m

Technophage, sa has 11 - 50 employees.